Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While animal studies and...
endocannabinoid system clinical research: CBD & Metabolic Health
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not improve glucose tolerance or meaningfully alter gut microbiome composition in sedentary adults with overweight or obesity. While epidemiological data suggest...